Hepaglide 1.7mg Injection

Q1: What is Hepaglide 1.7mg used for?

Hepaglide 1.7mg is a high-dose injectable semaglutide from Zydus Healthcare prescribed for advanced weight management in obesity. It is either a final maintenance dose for patients who achieve their goals here or a penultimate escalation step before 2.4mg.

Q2: Is Hepaglide 1.7mg equivalent to Wegovy 1.7mg?

Yes. Hepaglide 1.7mg contains the same semaglutide dose as Wegovy 1.7mg. As a bioequivalent Indian-manufactured product from Zydus Healthcare, it delivers the same clinical outcomes at significantly lower cost.

Q3: What is the advantage of Zydus Healthcare over other Indian semaglutide manufacturers?

Zydus Healthcare, part of Zydus Lifesciences, operates India's largest and most globally certified pharmaceutical manufacturing network, with 18 US FDA-approved facilities and presence in over 100 countries. This track record provides greater confidence in product consistency and quality.

Q4: How do I know if Hepaglide 1.7mg is working?

Signs of efficacy include noticeably reduced appetite and meal portions, progressive weight loss (typically 0.5–1.5 kg per week), improving fasting blood glucose, and decreased cravings for high-calorie foods. Laboratory HbA1c improvement is seen at 12-week checks.

Q5: Can I take Hepaglide 1.7mg if I am already on a VLCD?

A very low-calorie diet combined with high-dose semaglutide may produce very rapid weight loss, increasing risk of gallstones, nutritional deficiency, and lean mass loss. Inform your prescriber if you are on a structured very low-calorie diet so they can monitor you appropriately.

Q6: Is gallstone risk higher on Hepaglide 1.7mg than lower doses?

Rapid weight loss from any cause increases cholesterol saturation in bile, predisposing to gallstone formation. At 1.7mg, semaglutide produces significant weight loss, which is associated with higher gallstone incidence than lower doses. Report any right upper abdominal pain or shoulder-tip pain to your prescriber promptly.

Q7: Can Hepaglide 1.7mg cause anxiety or mood changes?

Mood changes including anxiety, irritability, or low mood have been reported with GLP-1 agonists, though causality is not established. Rare cases of suicidal ideation have been reported. If you experience significant mood changes, contact your prescriber without delay.

Q8: What vitamins should I take alongside Hepaglide 1.7mg?

At high semaglutide doses, food intake is substantially reduced. A daily multivitamin, vitamin D3 (if deficient), and adequate calcium intake are recommended. Iron and vitamin B12 monitoring may be appropriate for patients on long-term treatment with very low food intake.

Q9: Can Hepaglide 1.7mg be combined with topiramate for weight loss?

This combination is not standard practice in India and limited data exists on the combined safety profile. Topiramate is sometimes used off-label for weight loss but should not be combined with semaglutide without specialist prescriber oversight.

Q10: How do I handle the pen if I am visually impaired?

Most semaglutide auto-injector pens have tactile features and audible clicks that facilitate use by patients with visual impairment. A caregiver or nurse can assist. Inform your prescriber if visual impairment affects your ability to self-inject safely.